Gamma oscillation deficits and the onset and early progression of schizophrenia

Harvard Review of Psychiatry

Volumn 18, Issue 3, 2010, Pages 173-189

  Woo, Tsung Ung W ^a,b   Spencer, Kevin ^c   McCarley, Robert W ^a,b,d  

^a MCLEAN HOSPITAL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c VA BOSTON HEALTHCARE SYSTEM   (United States)

^d NONE

Author keywords

Adolescent development; GABA; NMDA; Parvalbumin; Synaptic pruning

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; CANNABIS; CLOZAPINE; HALOPERIDOL; METABOTROPIC RECEPTOR AGONIST; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROLEPTIC AGENT; OLANZAPINE; PARVALBUMIN;

BASKET CELL; BRAIN FUNCTION; CHANDELIER CELL; CLINICAL FEATURE; CLINICAL TRIAL; DISEASE COURSE; DRUG EFFICACY; ELECTROENCEPHALOGRAPHY; EXCITOTOXICITY; GAMMA OSCILLATION; HUMAN; INTERNEURON; NERVE CELL; NERVE CELL PLASTICITY; NERVE CONDUCTION; NERVE GROWTH; NEUROTRANSMISSION; NONHUMAN; OSCILLATION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; REVIEW; SCHIZOPHRENIA; SYMPTOMATOLOGY; SYNAPSE;

BRAIN; CEREBRAL CORTEX; DISEASE PROGRESSION; ELECTROENCEPHALOGRAPHY; HUMANS; NEURAL PATHWAYS; NEURONS; PARVALBUMINS; RECEPTORS, N-METHYL-D-ASPARTATE; SCHIZOPHRENIA; SYNAPSES;

EID: 77951718246     PISSN: 10673229     EISSN: 14657309     Source Type: Journal    
DOI: 10.3109/10673221003747609     Document Type: Review

References (279)

1. Bleuler E; J Zinkin, trans. Dementia praecox or the group of schizophrenias. New York: International Universities Press, 1950 [1911].
2. Andreasen NC. Schizophrenia: the fundamental questions. Brain Res Brain Res Rev 2000;31:106-112
3. Friston KJ, Frith CD. Schizophrenia: a disconnection syndrome? Clin Neurosci 1995;3:89-97.
4. Benes FM. Emerging principles of altered neural circuitry in schizophrenia. Brain Res Brain Res Rev Vis Neurosci 2000;31:251-269
5. Uhlhaas PJ, Singer W. Neural synchrony in brain disorders: relevance for cognitive dysfunctions and pathophysiology. Neuron 2006;52:155-168
6. Engel AK, Singer W. Temporal binding and the neural correlates of sensory awareness. Trends Cogn Sci 2001;5:16-25.
7. Singer W, Gray C, Engel A, Konig P, Artola A, Brocher S. Formation of cortical cell assemblies. Cold Spring Harb Symp Quant Biol 1990;55:939-952
8. Tallon-Baudry C. Attention and awareness in synchrony. Trends Cogn Sci 2004;8:523-525
9. Lee KH,Williams LM, BreakspearM, Gordon E. Synchronous gamma activity: a review and contribution to an integrative neuroscience model of schizophrenia. Brain Res Brain Res Rev 2003;41:57-78.
10. Herrmann CS, Demiralp T. Human EEG gamma oscillations in neuropsychiatric disorders. Clin Neurophysiol 2005;116:2719-2733
11. Lewis DA, Moghaddam B. Cognitive dysfunction in schizophrenia: convergence of gamma-aminobutyric acid and glutamate alterations. Arch Neurol 2006;63:1372-1376
12. Lewis DA, Hashimoto T, Volk DW. Cortical inhibitory neurons and schizophrenia. Nat Rev Neurosci 2005;6:312-324
13. Uhlhaas PJ, Haenschel C, Nikolic D, Singer W. The role of oscillations and synchrony in cortical networks and their putative relevance for the pathophysiology of schizophrenia. Schizophr Bull 2008;34:927-943
14. Gonzalez-Burgos G, Lewis DA. GABA neurons and the mechanisms of network oscillations: implications for understanding cortical dysfunction in schizophrenia. Schizophr Bull 2008;34:944-961
15. Spencer KM. Visual gamma oscillations in schizophrenia: implications for understanding neural circuitry abnormalities. Clin EEG Neurosci 2008;39:65-68
16. Roach BJ, Mathalon DH. Event-related EEG time-frequency analysis: an overview of measures and an analysis of early gamma band phase locking in schizophrenia. Schizophr Bull 2008;34:907-926
17. Woo TU, Crowell AL. Targeting synapses and myelin in the prevention of schizophrenia. Schizophr Res 2005;73:193-207.
18. Eckhorn R, Bauer R, Jordan W, et al. Coherent oscillations: a mechanism of feature linking in the visual cortex? Multiple electrode and correlation analyses in the cat. Biol Cybern 1988;60:121-130
19. Gray CM, Engel AK, Konig P, Singer W. Synchronization of oscillatory neuronal responses in cat striate cortex: temporal properties. Vis Neurosci 1992;8:337-347
20. Engel AK, Konig P, Singer W. Direct physiological evidence for scene segmentation by temporal coding. Proc Natl Acad Sci U S A 1991;88:9136-9140
21. Gray CM, Konig P, Engel AK, Singer W. Oscillatory responses in cat visual cortex exhibit inter-columnar synchronization which reflects global stimulus properties. Nature 1989;338:334-337
22. Gray CM, SingerW. Stimulus-specific neuronal oscillations in orientation columns of cat visual cortex. Proc Natl Acad Sci U S A 1989;86:1698-1702
23. Engel AK, Fries P, Singer W. Dynamic predictions: oscillations and synchrony in top-down processing. Nat Rev Neurosci 2001;2:704-716
24. Salinas E, Sejnowski TJ. Correlated neuronal activity and the flow of neural information. Nat Rev Neurosci 2001;2:539-550
25. Tiitinen H, Sinkkonen J, Reinikainen K, Alho K, Lavikainen J, Naatanen R. Selective attention enhances the auditory 40-Hz transient response in humans. Nature 1993;364:59-60.
26. Fries P, Reynolds JH, Rorie AE, Desimone R. Modulation of oscillatory neuronal synchronization by selective visual attention. Science 2001;291:1560-1563
27. Howard MW, Rizzuto DS, Caplan JB, et al. Gamma oscillations correlate with working memory load in humans. Cereb Cortex 2003;13:1369-1374
28. Tallon-Baudry C, Bertrand O, Peronnet F, Pernier J. Induced gamma-band activity during the delay of a visual short-term memory task in humans. J Neurosci 1998;18:4244-4254
29. De Pascalis V, Ray WJ. Effects of memory load on eventrelated patterns of 40-Hz EEG during cognitive and motor tasks. Int J Psychophysiol 1998;28:301-315
30. Fell J, Klaver P, Lehnertz K, et al. Human memory formation is accompanied by rhinal-hippocampal coupling and decoupling. Nat Neurosci 2001;4:1259-1264
31. Schoffelen JM, Oostenveld R, Fries P. Neuronal coherence as a mechanism of effective corticospinal interaction. Science 2005;308:111-113 (Pubitemid 40471009)
32. Tallon-Baudry C, Bertrand O. Oscillatory gamma activity in humans and its role in object representation. Trends Cogn Sci 1999;3:151-162
33. Javitt DC, Spencer KM, Thaker GK, Winterer G, Hajos M. Neurophysiological biomarkers for drug development in schizophrenia. Nat Rev Drug Discov 2008;7:68-83.
34. Engel AK, Konig P, Kreiter AK, Schillen TB, Singer W. Temporal coding in the visual cortex: new vistas on integration in the nervous system. Trends Neurosci 1992;15:218-226
35. Pulvermuller F, Lutzenberger W, Preissl H. Nouns and verbs in the intact brain: evidence from event-related potentials and high-frequency cortical responses. Cereb Cortex 1999;9:497-506.
36. Galambos R, Makeig S, Talmachoff PJ. A 40-Hz auditory potential recorded from the human scalp. Proc Natl Acad Sci U S A 1981;78:2643-2647
37. Light GA, Hsu JL, Hsieh MH, et al. Gamma band oscillations reveal neural network cortical coherence dysfunction in schizophrenia patients. Biol Psychiatry 2006;60:1231-1240
38. Hong LE, Summerfelt A, McMahon R, et al. Evoked gamma band synchronization and the liability for schizophrenia. Schizophr Res 2004;70:293-302.
39. Brenner CA, Sporns O, Lysaker PH, O'Donnell BF. EEG synchronization to modulated auditory tones in schizophrenia, schizoaffective disorder, and schizotypal personality disorder. Am J Psychiatry 2003;160:2238-2240
40. Kwon JS, O'Donnell BF, Wallenstein GV, et al. Gamma frequency-range abnormalities to auditory stimulation in schizophrenia. Arch Gen Psychiatry 1999;56:1001-1005
41. Wilson TW, Hernandez OO, Asherin RM, Teale PD, Reite ML, Rojas DC. Cortical gamma generators suggest abnormal auditory circuitry in early-onset psychosis. Cereb Cortex 2008;18:371-378
42. Spencer KM, Salisbury DF, Shenton ME, McCarley RW. Gamma-band auditory steady-state responses are impaired in first episode psychosis. Biol Psychiatry 2008;64:369-375
43. Spencer KM, Niznikiewicz MA, Shenton ME, McCarley RW. Sensory-evoked gamma oscillations in chronic schizophrenia. Biol Psychiatry 2008;63:744-747
44. Spencer KM, Nestor PG, Niznikiewicz MA, Salisbury DF, Shenton ME, McCarley RW. Abnormal neural synchrony in schizophrenia. J Neurosci 2003;23:7407-7411
45. Gallinat J, Winterer G, Herrmann CS, Senkowski D. Reduced oscillatory gamma-band responses in unmedicated schizophrenic patients indicate impaired frontal network processing. Clin Neurophysiol 2004;115:1863-1874
46. Clementz BA, Blumenfeld LD, Cobb S. The gamma band response may account for poor P50 suppression in schizophrenia. Neuroreport 1997;8:3889-3893
47. Hong LE, Summerfelt A,McMahon RP, Thaker GK, Buchanan RW. Gamma/beta oscillation and sensory gating deficit in schizophrenia. Neuroreport 2004;15:155-159
48. Haig AR, Gordon E, De Pascalis V, Meares RA, Bahramali H, Harris A. Gamma activity in schizophrenia: evidence of impaired network binding? Clin Neurophysiol 2000;111:1461-1468
49. Symond MB, Harris AW, Gordon E, Williams LM. "Gamma synchrony" in first-episode schizophrenia: a disorder of temporal connectivity? Am J Psychiatry 2005;162:459-465
50. Wynn JK, Light GA, Breitmeyer B, Nuechterlein KH, Green MF. Event-related gamma activity in schizophrenia patients during a visual backward-masking task. Am J Psychiatry 2005;162:2330-2336
51. Spencer KM, Nestor PG, Perlmutter R, et al. Neural synchrony indexes disordered perception and cognition in schizophrenia. Proc Natl Acad Sci U S A 2004;101:17288-17293
52. Lee KH, Williams LM, Haig A, Gordon E. "Gamma (40 Hz) phase synchronicity" and symptom dimensions in schizophrenia. Cognit Neuropsychiatry 2003;8:57-71.
53. Goldman-Rakic PS. Working memory dysfunction in schizophrenia. J Neuropsychiatry Clin Neurosci 1994;6:348-357
54. Park S, Holzman PS. Schizophrenics show spatial working memory deficits. Arch Gen Psychiatry 1992;49:975-982
55. Lewis DA, Gonzalez-Burgos G. Neuroplasticity of neocortical circuits in schizophrenia. Neuropsychopharmacology 2008;33:141-165
56. Tan HY, Callicott JH, Weinberger DR. Dysfunctional and compensatory prefrontal cortical systems, genes and the pathogenesis of schizophrenia. Cereb Cortex 2007;17 suppl 1:i171-81.
57. Kissler J, Muller MM, Fehr T, Rockstroh B, Elbert T. MEG gamma band activity in schizophrenia patients and healthy subjects in a mental arithmetic task and at rest. Clin Neurophysiol 2000;111:2079-2087
58. Cho RY, Konecky RO, Carter CS. Impairments in frontal cortical gamma synchrony and cognitive control in schizophrenia. Proc Natl Acad Sci U S A 2006;103:19878-19883
59. Basar-Eroglu C, Brand A, Hildebrandt H, Karolina Kedzior K, Mathes B, Schmiedt C. Working memory related gamma oscillations in schizophrenia patients. Int J Psychophysiol 2007;64:39-45.
60. Gottesman, II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 2003;160:636-645
61. Voglmaier MM, Seidman LJ, Salisbury D, McCarley RW. Neuropsychological dysfunction in schizotypal personality disorder: a profile analysis. Biol Psychiatry 1997;41:530-540
62. Gur RE, Calkins ME, Gur RC, et al. The Consortium on the Genetics of Schizophrenia: neurocognitive endophenotypes. Schizophr Bull 2007;33:49-68.
63. Faraone SV, Seidman LJ, Kremen WS, Toomey R, Pepple JR, Tsuang MT. Neuropsychological functioning among the nonpsychotic relatives of schizophrenic patients: a 4-year follow-up study. J Abnorm Psychol 1999;108:176-181
64. Seidman LJ, Giuliano AJ, Smith CW, et al. Neuropsychological functioning in adolescents and young adults at genetic risk for schizophrenia and affective psychoses: results from the Harvard and Hillside Adolescent High Risk Studies. Schizophr Bull 2006;32:507-524
65. Ford JM, Roach BJ, Faustman WO, Mathalon DH. Out-ofsynch and out-of-sorts: dysfunction of motor-sensory communication in schizophrenia. Biol Psychiatry 2008;63:736-743
66. Ribary U, Ioannides AA, Singh KD, et al. Magnetic field tomography of coherent thalamocortical 40-Hz oscillations in humans. Proc Natl Acad Sci U S A 1991;88:11037-11041
67. Welsh JP, Ahn ES, Placantonakis DG. Is autism due to brain desynchronization? Int J Dev Neurosci 2005;23:253-263
68. Wilson TW, Rojas DC, Reite ML, Teale PD, Rogers SJ. Children and adolescents with autism exhibit reduced MEG steady-state gamma responses. Biol Psychiatry 2007;62:192-197
69. Kalanithi PS, Zheng W, Kataoka Y, et al. Altered parvalbumin-positive neuron distribution in basal ganglia of individuals with Tourette syndrome. Proc Natl Acad Sci U S A 2005;102:13307-13312
70. Leckman JF, Vaccarino FM, Kalanithi PS, Rothenberger A. Annotation: Tourette syndrome: a relentless drumbeat-driven by misguided brain oscillations. J Child Psychol Psychiatry 2006;47:537-550
71. O'Donnell BF, Hetrick WP, Vohs JL, Krishnan GP, Carroll CA, Shekhar A. Neural synchronization deficits to auditory stimulation in bipolar disorder. Neuroreport 2004;15:1369-1372
72. Bhattacharya J. Reduced degree of long-range phase synchrony in pathological human brain. Acta Neurobiol Exp (Wars) 2001;61:309-318
73. Yordanova J, Banaschewski T, Kolev V, Woerner W, Rothenberger A. Abnormal early stages of task stimulus processing in children with attention-deficit hyperactivity disorder-evidence from event-related gamma oscillations. Clin Neurophysiol 2001;112:1096-1108
74. Slewa-Younan S, Green AM, Baguley IJ, Felmingham KL, Haig AR, Gordon E. Is 'gamma' (40 Hz) synchronous activity disturbed in patients with traumatic brain injury? Clin Neurophysiol 2002;113:1640-1646
75. Ahveninen J, Kahkonen S, Tiitinen H, et al. Suppression of transient 40-Hz auditory response by haloperidol suggests modulation of human selective attention by dopamine D2 receptors. Neurosci Lett 2000;292:29-32.
76. Sperling W, Vieth J, Martus M, Demling J, Barocka A. Spontaneous slow and fast MEG activity in male schizophrenics treated with clozapine. Psychopharmacology (Berl) 1999;142:375-382
77. Buzsaki G. Rhythms of the brain. New York: Oxford University Press, 2006.
78. Kopell N, Ermentrout GB, Whittington MA, Traub RD. Gamma rhythms and beta rhythms have different synchronization properties. Proc Natl Acad Sci U S A 2000;97:1867-1872
79. Uhlhaas PJ, Linden DE, Singer W, et al. Dysfunctional longrange coordination of neural activity during Gestalt perception in schizophrenia. J Neurosci 2006;26:8168-8175
80. Yeragani VK, Cashmere D, Miewald J, Tancer M, Keshavan MS. Decreased coherence in higher frequency ranges (beta and gamma) between central and frontal EEG in patients with schizophrenia: a preliminary report. Psychiatry Res 2006;141:53-60.
81. Koenig T, Lehmann D, Saito N, Kuginuki T, Kinoshita T, Koukkou M. Decreased functional connectivity of EEG theta-frequency activity in first-episode, neuroleptic-naive patients with schizophrenia: preliminary results. Schizophr Res 2001;50:55-60.
82. Schmiedt C, Brand A, Hildebrandt H, Basar-Eroglu C. Eventrelated theta oscillations during working memory tasks in patients with schizophrenia and healthy controls. Brain Res Cogn Brain Res 2005;25:936-947
83. Jin Y, Potkin SG, Sandman CA, Bunney WE Jr. Electroencephalographic photic driving in patients with schizophrenia and depression. Biol Psychiatry 1997;41:496-499
84. Benes FM, Berretta S. GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder. Neuropsychopharmacology 2001;25:1-27.
85. Costa E, Davis JM, Dong E, et al. A GABAergic cortical deficit dominates schizophrenia pathophysiology. Crit Rev Neurobiol 2004;16:1-23.
86. Whittington MA, Traub RD, Kopell N, Ermentrout B, Buhl EH. Inhibition-based rhythms: experimental and mathematical observations on network dynamics. Int J Psychophysiol 2000;38:315-336
87. Brunel N, Wang XJ. Effects of neuromodulation in a cortical network model of object working memory dominated by recurrent inhibition. J Comput Neurosci 2001;11:63-85.
88. Costa E, Davis J, Grayson DR, Guidotti A, Pappas GD, Pesold C. Dendritic spine hypoplasticity and downregulation of reelin and GABAergic tone in schizophrenia vulnerability. Neurobiol Dis 2001;8:723-742
89. Keverne EB. GABA-ergic neurons and the neurobiology of schizophrenia and other psychoses. Brain Res Bull 1999;48:467-473
90. Ohnuma T, Augood SJ, Arai H, McKenna PJ, Emson PC. Measurement of GABAergic parameters in the prefrontal cortex in schizophrenia: focus on GABA content, GABA(A) receptor alpha-1 subunit messenger RNA and human GABA transporter-1 (HGAT-1) messenger RNA expression. Neuroscience 1999;93:441-448
91. Akbarian S, Kim JJ, Potkin SG, et al. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch Gen Psychiatry 1995;52:258-266
92. Volk DW, Austin MC, Pierri JN, Sampson AR, Lewis DA. Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gammaaminobutyric acid neurons in subjects with schizophrenia. Arch Gen Psychiatry 2000;57:237-245
93. Hashimoto T, Volk DW, Eggan SM, et al. Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. J Neurosci 2003;23:6315-6326
94. Guidotti A, Auta J, Davis JM, et al. Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. Arch Gen Psychiatry 2000;57:1061-1069
95. Woo TU, Walsh JP, Benes FM. Density of glutamic acid decarboxylase 67 messenger RNA-containing neurons that express the N-methyl-D-aspartate receptor subunit NR2A in the anterior cingulate cortex in schizophrenia and bipolar disorder. Arch Gen Psychiatry 2004;61:649-657
96. Volk D, Austin M, Pierri J, Sampson A, Lewis D. GABA transporter-1mRNA in the prefrontal cortex in schizophrenia: decreased expression in a subset of neurons. Am J Psychiatry 2001;158:256-265 (Pubitemid 32116522)
97. Akbarian S, Huang HS.Molecular and cellularmechanisms of altered GAD1/GAD67 expression in schizophrenia and related disorders. Brain Res Rev 2006;52:293-304.
98. Selemon LD, Goldman-Rakic PS. The reduced neuropil hypothesis: a circuit based model of schizophrenia. Biol Psychiatry 1999;45:17-25.
99. Newell KA, Zavitsanou K, Jew SK, Huang XF. Alterations of muscarinic and GABA receptor binding in the posterior cingulate cortex in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2007;31:225-233
100. Benes FM, Khan Y, Vincent SL, Wickramasinghe R. Differences in the subregional and cellular distribution of GABAA receptor binding in the hippocampal formation of schizophrenic brain. Synapse 1996;22:338-349
101. Benes FM, Vincent SL, Alsterberg G, Bird ED, SanGiovanni JP. Increased GABAA receptor binding in superficial layers of cingulate cortex in schizophrenics. J Neurosci 1992;12:924-929
102. Hashimoto T, Arion D, Unger T, et al. Alterations in GABArelated transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia. Mol Psychiatry 2008;13:147-161
103. Kim A, Matzilevich D, Walsh JP, Benes FM, Woo TUW. Parvalbumin-containing neurons and disturbances of prefrontal cortical circuitry in schizophrenia. Soc Neurosci Abstr 2005;34.
104. Volk DW, Pierri JN, Fritschy JM, Auh S, Sampson AR, Lewis DA. Reciprocal alterations in pre- and postsynaptic inhibitory markers at chandelier cell inputs to pyramidal neurons in schizophrenia. Cereb Cortex 2002;12:1063-1070
105. Wang Y, Gupta A, Toledo-Rodriguez M, Wu CZ, Markram H. Anatomical, physiological, molecular and circuit properties of nest basket cells in the developing somatosensory cortex. Cereb Cortex 2002;12:395-410.
106. Kawaguchi Y, Kondo S. Parvalbumin, somatostatin and cholecystokinin as chemical markers for specific GABAergic interneuron types in the rat frontal cortex. J Neurocytol 2002;31:277-287
107. Kawaguchi Y, Kubota Y. GABAergic cell subtypes and their synaptic connections in rat frontal cortex. Cereb Cortex 1997;7:476-486
108. Gabbott PL, Bacon SJ. Local circuit neurons in the medial prefrontal cortex (areas 24a,b,c, 25 and 32) in the monkey: I. Cell morphology and morphometrics. J Comp Neurol 1996;364:567-608.
109. Wang XJ, Tegner J, Constantinidis C, Goldman-Rakic PS. Division of labor among distinct subtypes of inhibitory neurons in a cortical microcircuit of working memory. Proc Natl Acad Sci U S A 2004;101:1368-1373
110. Markram H, Toledo-Rodriguez M, Wang Y, Gupta A, Silberberg G, Wu C. Interneurons of the neocortical inhibitory system. Nat Rev Neurosci 2004;5:793-807.
111. Soltesz I. Diversity in the neuronalmachine. New York:Oxford University Press, 2005.
112. Soltesz I, Deschenes M. Low- and high-frequency membrane potential oscillations during theta activity in CA1 and CA3 pyramidal neurons of the rat hippocampus under ketaminexylazine anesthesia. J Neurophysiol 1993;70:97-116.
113. Hajos N, Palhalmi J,Mann EO, Nemeth B, Paulsen O, Freund TF. Spike timing of distinct types of GABAergic interneuron during hippocampal gamma oscillations in vitro. J Neurosci 2004;24:9127-9137
114. Klausberger T, Magill PJ, Marton LF, et al. Brain-state- and cell-type-specific firing of hippocampal interneurons in vivo. Nature 2003;421:844-848
115. Cunningham MO, Hunt J, Middleton S, et al. Region-specific reduction in entorhinal gamma oscillations and parvalbuminimmunoreactive neurons in animal models of psychiatric illness. J Neurosci 2006;26:2767-2776
116. Bartos M, Vida I, Jonas P. Synaptic mechanisms of synchronized gamma oscillations in inhibitory interneuron networks. Nat Rev Neurosci 2007;8:45-56.
117. Howard A, Tamas G, Soltesz I. Lighting the chandelier: new vistas for axo-axonic cells. Trends Neurosci 2005;28:310-316
118. Freund TF. Interneuron diversity series: rhythm and mood in perisomatic inhibition. Trends Neurosci 2003;26:489-495
119. Somogyi P, Kisvarday ZF,MartinKA, WhitteridgeD. Synaptic connections of morphologically identified and physiologically characterized large basket cells in the striate cortex of cat. Neuroscience 1983;10:261-294
120. DeFelipe J, Gonzalez-Albo MC. Chandelier cell axons are immunoreactive for GAT-1 in the human neocortex. Neuroreport 1998;9:467-470
121. Inda MC, Defelipe J, Munoz A. The distribution of chandelier cell axon terminals that express the GABA plasma membrane transporter GAT-1 in the human neocortex. Cereb Cortex 2007;17:2060-2071
122. Woo TU, Whitehead RE, Melchitzky DS, Lewis DA. A subclass of prefrontal gamma-aminobutyric acid axon terminals are selectively altered in schizophrenia. Proc Natl Acad Sci U S A 1998;95:5341-5346
123. Pierri JN, Chaudry AS, Woo TU, Lewis DA. Alterations in chandelier neuron axon terminals in the prefrontal cortex of schizophrenic subjects. Am J Psychiatry 1999;156:1709-1719
124. Csicsvari J, Jamieson B, Wise KD, Buzsaki G. Mechanisms of gamma oscillations in the hippocampus of the behaving rat. Neuron 2003;37:311-322
125. Tamas G, Buhl EH, Lorincz A, Somogyi P. Proximally targeted GABAergic synapses and gap junctions synchronize cortical interneurons. Nat Neurosci 2000;3:366-371
126. Mann EO, Suckling JM, Hajos N, Greenfield SA, Paulsen O. Perisomatic feedback inhibition underlies cholinergically induced fast network oscillations in the rat hippocampus in vitro. Neuron 2005;45:105-117
127. Kawaguchi Y. Physiological subgroups of nonpyramidal cells with specific morphological characteristics in layer II/III of rat frontal cortex. J Neurosci 1995;15:2638-2655
128. Krimer LS, Zaitsev AV, Czanner G, et al. Cluster analysis-based physiological classification and morphological properties of inhibitory neurons in layers 2-3 of monkey dorsolateral prefrontal cortex. J Neurophysiol 2005;94:3009-3022
129. Zaitsev AV, Gonzalez-Burgos G, Povysheva NV, Kroner S, Lewis DA, Krimer LS. Localization of calcium-binding proteins in physiologically and morphologically characterized interneurons of monkey dorsolateral prefrontal cortex. Cereb Cortex 2005;15:1178-1186
130. Newcomer JW, Krystal JH. NMDA receptor regulation of memory and behavior in humans. Hippocampus 2001;11:529-542
131. Javitt DC, Zukin SR. Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 1991;148:1301-1308
132. Krystal JH, Karper LP, Seibyl JP, et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 1994;51:199-214.
133. Olney JW, Farber NB. Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry 1995;52:998-1007.
134. Olney JW, Newcomer JW, Farber NB. NMDA receptor hypofunction model of schizophrenia. J Psychiatr Res 1999;33:523-533
135. Greene R, Bergeron R, McCarley R, Coyle JT, Grunze H. Short-term and long-term effects of N-methyl-D-aspartate receptor hypofunction.ArchGen Psychiatry 2000;57:1180-1; author reply 1182-1183
136. Grunze HC, Rainnie DG, Hasselmo ME, et al. NMDAdependent modulation of CA1 local circuit inhibition. J Neurosci 1996;16:2034-2043
137. Woo TU, Kim AM, Viscidi E. Disease-specific alterations in glutamatergic neurotransmission on inhibitory interneurons in the prefrontal cortex in schizophrenia. Brain Res 2008;1218:267-277
138. Kaneko T, Fujiyama F. Complementary distribution of vesicular glutamate transporters in the central nervous system. Neurosci Res 2002;42:243-250
139. Fujiyama F, Furuta T, Kaneko T. Immunocytochemical localization of candidates for vesicular glutamate transporters in the rat cerebral cortex. J Comp Neurol 2001;435:379-387
140. Eastwood SL, Harrison PJ. Decreased expression of vesicular glutamate transporter 1 and complexin II mRNAs in schizophrenia: further evidence for a synaptic pathology affecting glutamate neurons. Schizophr Res 2005;73:159-172
141. Kinney JW, Davis CN, Tabarean I, Conti B, Bartfai T, Behrens MM. A specific role for NR2A-containing NMDA receptors in the maintenance of parvalbumin and GAD67 immunoreactivity in cultured interneurons. J Neurosci 2006;26:1604-1615
142. Cochran SM, Kennedy M, McKerchar CE, Steward LJ, Pratt JA,Morris BJ. Induction ofmetabolic hypofunction and neurochemical deficits after chronic intermittent exposure to phencyclidine: differentialmodulation by antipsychotic drugs. Neuropsychopharmacology 2003;28:265-275
143. Braun I, Genius J, Grunze H, Bender A, Moller HJ, Rujescu D. Alterations of hippocampal and prefrontal GABAergic interneurons in an animal model of psychosis induced by NMDA receptor antagonism. Schizophr Res 2007;97:254-263
144. Reynolds GP, Abdul-Monim Z, Neill JC, Zhang ZJ. Calcium binding protein markers of GABA deficits in schizophrenia-postmortem studies and animal models. Neurotox Res 2004;6:57-61.
145. Keilhoff G, Becker A, Grecksch G, Wolf G, Bernstein HG. Repeated application of ketamine to rats induces changes in the hippocampal expression of parvalbumin, neuronal nitric oxide synthase and cFOS similar to those found in human schizophrenia. Neuroscience 2004;126:591-598
146. Abdul-Monim Z, Neill JC, Reynolds GP. Sub-chronic psychotomimetic phencyclidine induces deficits in reversal learning and alterations in parvalbumin-immunoreactive expression in the rat. J Psychopharmacol 2007;21:198-205.
147. Rujescu D, Bender A, Keck M, et al. A pharmacological model for psychosis based on N-methyl-D-aspartate receptor hypofunction: molecular, cellular, functional and behavioral abnormalities. Biol Psychiatry 2006;59:721-729
148. Morrow BA, Elsworth JD, Roth RH. Repeated phencyclidine in monkeys results in loss of parvalbumin-containing axoaxonic projections in the prefrontal cortex. Psychopharmacology (Berl) 2007;192:283-290
149. Bitanihirwe BK, Lim MP, Kelley JF, Kaneko T, Woo T-UW. Glutamatergic deficits and parvalbumin-containing neurons in the prefrontal cortex in schizophrenia. BMC Psychiatry 2009;9:71.
150. Lisman JE, Coyle JT, Green RW, et al. Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends Neurosci 2008;31:234-242
151. Glantz LA, Gilmore JH, Lieberman JA, Jarskog LF. Apoptoticmechanisms and the synaptic pathology of schizophrenia. Schizophr Res 2006;81:47-63.
152. Jarskog LF, Glantz LA, Gilmore JH, Lieberman JA. Apoptotic mechanisms in the pathophysiology of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2005;29:846-858
153. Bernstein M, Lichtman JW. Axonal atrophy: the retraction reaction. Curr Opin Neurobiol 1999;9:364-370
154. Gilman CP, Mattson MP. Do apoptotic mechanisms regulate synaptic plasticity and growth-cone motility? Neuromolecular Med 2002;2:197-214.
155. Garden GA, Budd SL, Tsai E, et al. Caspase cascades in human immunodeficiency virus-associated neurodegeneration. J Neurosci 2002;22:4015-4024
156. Mattson MP, Keller JN, Begley JG. Evidence for synaptic apoptosis. Exp Neurol 1998;153:35-48.
157. McGlashan TH, Hoffman RE. Schizophrenia as a disorder of developmentally reduced synaptic connectivity. Arch Gen Psychiatry 2000;57:637-648
158. Kalus P, Muller TJ, Zuschratter W, Senitz D. The dendritic architecture of prefrontal pyramidal neurons in schizophrenic patients. Neuroreport 2000;11:3621-3625
159. Garey LJ, Ong WY, Patel TS, et al. Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia. J Neurol Neurosurg Psychiatry 1998;65:446-453
160. Glantz LA, Lewis DA. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch Gen Psychiatry 2000;57:65-73.
161. Mirnics K, Middleton FA, Lewis DA, Levitt P. Analysis of complex brain disorders with gene expression microarrays: schizophrenia as a disease of the synapse. Trends Neurosci 2001;24:479-486
162. Shenton ME, Dickey CC, Frumin M, McCarley RW. A review of MRI findings in schizophrenia. Schizophr Res 2001;49: 1-52.
163. Dorph-Petersen KA, Pierri JN, Perel JM, Sun Z, Sampson AR, Lewis DA. The influence of chronic exposure to antipsychotic medications on brain size before and after tissue fixation: a comparison of haloperidol and olanzapine in macaque monkeys. Neuropsychopharmacology 2005;30:1649-1661
164. Lieberman JA, Tollefson GD, Charles C, et al. Antipsychotic drug effects on brain morphology in first-episode psychosis. Arch Gen Psychiatry 2005;62:361-370
165. Eastwood SL, Burnet PW, Harrison PJ. Altered synaptophysin expression as a marker of synaptic pathology in schizophrenia. Neuroscience 1995;66:309-319
166. Glantz LA, Lewis DA. Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity. Arch Gen Psychiatry 1997;54:660-669
167. Halim ND, Weickert CS, McClintock BW, et al. Presynaptic proteins in the prefrontal cortex of patients with schizophrenia and rats with abnormal prefrontal development. Mol Psychiatry 2003;8:797-810.
168. HonerWG, Falkai P, Bayer TA, et al. Abnormalities of SNARE mechanism proteins in anterior frontal cortex in severe mental illness. Cereb Cortex 2002;12:349-356
169. Davidsson P, Gottfries J, Bogdanovic N, et al. The synapticvesicle- specific proteins rab3a and synaptophysin are reduced in thalamus and related cortical brain regions in schizophrenic brains. Schizophr Res 1999;40:23-29
170. Sawada K, Young CE, Barr AM, et al. Altered immunoreactivity of complexin protein in prefrontal cortex in severe mental illness. Mol Psychiatry 2002;7:484-492
171. Glantz LA, Austin MC, Lewis DA. Normal cellular levels of synaptophysin mRNA expression in the prefrontal cortex of subjects with schizophrenia. Biol Psychiatry 2000;48:389-397
172. Eastwood SL, Cairns NJ, Harrison PJ. Synaptophysin gene expression in schizophrenia. Investigation of synaptic pathology in the cerebral cortex. Br J Psychiatry 2000;176:236-242
173. Karson CN, Mrak RE, Schluterman KO, Sturner WQ, Sheng JG, Griffin WS. Alterations in synaptic proteins and their encoding mRNAs in prefrontal cortex in schizophrenia: a possible neurochemical basis for 'hypofrontality.' Mol Psychiatry 1999;4:39-45.
174. Pongrac J, Middleton FA, Lewis DA, Levitt P, Mirnics K. Gene expression profiling with DNA microarrays: advancing our understanding of psychiatric disorders. Neurochem Res 2002;27:1049-1063
175. Mirnics K, Middleton FA, Marquez A, Lewis DA, Levitt P. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron 2000;28:53-67.
176. Vawter MP, Barrett T, Cheadle C, et al. Application of cDNA microarrays to examine gene expression differences in schizophrenia. Brain Res Bull 2001;55:641-650
177. Hakak Y, Walker JR, Li C, et al. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci U S A 2001;98:4746-4751
178. Lehrmann E, Hyde TM, VawterMP, Becker KG, Kleinman JE, Freed WJ. The use of microarrays to characterize neuropsychiatric disorders: postmortem studies of substance abuse and schizophrenia. Curr Mol Med 2003;3:437-446
179. Pucak ML, Levitt JB, Lund JS, Lewis DA. Patterns of intrinsic and associational circuitry in monkey prefrontal cortex. J Comp Neurol 1996;376:614-630
180. Sweet RA, Pierri JN, Auh S, Sampson AR, Lewis DA. Reduced pyramidal cell somal volume in auditory association cortex of subjects with schizophrenia. Neuropsychopharmacology 2003;28:599-609.
181. Pierri JN, Volk CL, Auh S, Sampson A, Lewis DA. Decreased somal size of
182. Black JE, Kodish IM, Grossman AW, et al. Pathology of layer V pyramidal neurons in the prefrontal cortex of patients with schizophrenia. Am J Psychiatry 2004;161:742-744
183. Lieberman JA. Is schizophrenia a neurodegenerative disorder? A clinical and neurobiological perspective. Biol Psychiatry 1999;46:729-739
184. Keshavan MS. Development, disease and degeneration in schizophrenia: a unitary pathophysiological model. J Psychiatr Res 1999;33:513-521
185. Weinberger DR. Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 1987;44:660-669
186. Lewis DA, Levitt P. Schizophrenia as a disorder of neurodevelopment. Annu Rev Neurosci 2002;25:409-432
187. Szabadics J, Varga C, Molnar G, Olah S, Barzo P, Tamas G. Excitatory effect of GABAergic axo-axonic cells in cortical microcircuits. Science 2006;311:233-235
188. Whittington MA, Traub RD. Interneuron diversity series: inhibitory interneurons and network oscillations in vitro. Trends Neurosci 2003;26:676-682
189. Buzsaki G, Geisler C, Henze DA, Wang XJ. Interneuron diversity series: circuit complexity and axon wiring economy of cortical interneurons. Trends Neurosci 2004;27:186-193
190. Traub RD, Spruston N, Soltesz I, Konnerth A, Whittington MA, Jefferys GR. Gamma-frequency oscillations: a neuronal population phenomenon, regulated by synaptic and intrinsic cellular processes, and inducing synaptic plasticity. Prog Neurobiol 1998;55:563-575
191. Pike FG, Goddard RS, Suckling JM, Ganter P, Kasthuri N, Paulsen O. Distinct frequency preferences of different types of rat hippocampal neurones in response to oscillatory input currents. J Physiol 2000;529 pt 1:205-213
192. Steriade M, Timofeev I, Durmuller N, Grenier F. Dynamic properties of corticothalamic neurons and local cortical interneurons generating fast rhythmic (30-40 Hz) spike bursts. J Neurophysiol 1998;79:483-490
193. Buzsaki G, Draguhn A. Neuronal oscillations in cortical networks. Science 2004;304:1926-1929
194. Xu Q, Cobos I, De La Cruz E, Rubenstein JL, Anderson SA. Origins of cortical interneuron subtypes. J Neurosci 2004;24:2612-2622
195. Wonders CP, Anderson SA. The origin and specification of cortical interneurons. Nat Rev Neurosci 2006;7:687-696
196. Gao WJ, Wormington AB, Newman DE, Pallas SL. Development of inhibitory circuitry in visual and auditory cortex of postnatal ferrets: immunocytochemical localization of calbindin- and parvalbumin-containing neurons. J Comp Neurol 2000;422:140-157
197. Patz S, Grabert J, Gorba T, Wirth MJ, Wahle P. Parvalbumin expression in visual cortical interneurons depends on neuronal activity and TrkB ligands during an early period of postnatal development. Cereb Cortex 2004;14: 342-351
198. de Lecea L, del Rio JA, Soriano E.Developmental expression of parvalbumin mRNA in the cerebral cortex and hippocampus of the rat. Brain Res Mol Brain Res 1995;32:1-13.
199. Alcantara S, Ferrer I. Postnatal development of parvalbumin immunoreactivity in the cerebral cortex of the cat. J Comp Neurol 1994;348:133-149 (Pubitemid 24294684)
200. Hensch TK. Critical period plasticity in local cortical circuits. Nat Rev Neurosci 2005;6:877-888
201. Jiang B, Huang ZJ, Morales B, Kirkwood A. Maturation of GABAergic transmission and the timing of plasticity in visual cortex. Brain Res Brain Res Rev 2005;50:126-133
202. Tropea D, Kreiman G, Lyckman A, et al. Gene expression changes and molecular pathways mediating activity-dependent plasticity in visual cortex. Nat Neurosci 2006;9:660-668
203. Gianfranceschi L, Siciliano R, Walls J, et al. Visual cortex is rescued from the effects of dark rearing by overexpression of BDNF. Proc Natl Acad Sci U S A 2003;100:12486-12491
204. Huang ZJ, Kirkwood A, Pizzorusso T, et al. BDNF regulates thematuration of inhibition and the critical period of plasticity in mouse visual cortex. Cell 1999;98:739-755
205. Hanover JL, Huang ZJ, Tonegawa S, Stryker MP. Brainderived neurotrophic factor overexpression induces precocious critical period in mouse visual cortex. J Neurosci 1999;19:RC40.
206. Gorba T,Wahle P. Expression of TrkB and TrkC but not BDNF mRNA in neurochemically identified interneurons in rat visual cortex in vivo and in organotypic cultures. Eur J Neurosci 1999;11:1179-1190
207. Cellerino A, Maffei L, Domenici L. The distribution of brain-derived neurotrophic factor and its receptor trkB in parvalbumin-containing neurons of the rat visual cortex. Eur J Neurosci 1996;8:1190-1197
208. Bourgeois JP, Goldman-Rakic PS, Rakic P. Synaptogenesis in the prefrontal cortex of rhesus monkeys. Cereb Cortex 1994;4:78-96.
209. Huttenlocher PR. Synaptic density in human frontal cortex-developmental changes and effects of aging. Brain Res 1979;163:195-205.
210. Woo TU, Pucak ML, Kye CH, Matus CV, Lewis DA. Peripubertal refinement of the intrinsic and associational circuitry in monkey prefrontal cortex. Neuroscience 1997;80:1149-1158
211. Anderson SA, Classey JD, Conde F, Lund JS, Lewis DA. Synchronous development of pyramidal neuron dendritic spines and parvalbumin-immunoreactive chandelier neuron axon terminals in layer III of monkey prefrontal cortex. Neuroscience 1995;67:7-22.
212. Erickson SL, Lewis DA. Postnatal development of parvalbumin- and GABA transporter-immunoreactive axon terminals in monkey prefrontal cortex. J Comp Neurol 2002;448: 186-202.
213. Rojas DC, Maharajh K, Teale PD, et al. Development of the 40Hz steady state auditory evoked magnetic field from ages 5 to 52. Clin Neurophysiol 2006;117:110-117
214. Poulsen C, Picton TW, Paus T. Age-related changes in transient and oscillatory brain responses to auditory stimulation in healthy adults 19-45 years old. Cereb Cortex 2007;17:1454-1467
215. Ohira K, Shimizu K, Hayashi M. Change of expression of fulllength and truncated TrkBs in the developing monkey central nervous system. Brain Res Dev Brain Res 1999;112:21-29
216. Webster MJ,Weickert CS, Herman MM, Kleinman JE. BDNF mRNA expression during postnatal development, maturation and aging of the human prefrontal cortex. Brain ResDev Brain Res 2002;139:139-150
217. Hayashi M, Mitsunaga F, Itoh M, Shimizu K, Yamashita A. Development of full-length Trk B-immunoreactive structures in the prefrontal and visual cortices of the macaque monkey. Anat Embryol (Berl) 2000;201:139-147
218. Weickert CS, Hyde TM, Lipska BK, Herman MM, Weinberger DR, Kleinman JE. Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia. Mol Psychiatry 2003;8:592-610.
219. Hashimoto T, Bergen SE, Nguyen QL, et al. Relationship of brain-derived neurotrophic factor and its receptor TrkB to altered inhibitory prefrontal circuitry in schizophrenia. J Neurosci 2004;25:372-383
220. Shimizu E, Hashimoto K, Watanabe H, et al. Serum brainderived neurotrophic factor (BDNF) levels in schizophrenia are indistinguishable from controls. Neurosci Lett 2003;351:111-114
221. Pirildar S, Gonul AS, Taneli F, Akdeniz F. Low serum levels of brain-derived neurotrophic factor in patients with schizophrenia do not elevate after antipsychotic treatment. Prog Neuropsychopharmacol Biol Psychiatry 2004;28:709-713
222. Toyooka K, Asama K, Watanabe Y, et al. Decreased levels of brain-derived neurotrophic factor in serum of chronic schizophrenic patients. Psychiatry Res 2002;110:249-257
223. Tan YL, Zhou DF, Cao LY, Zou YZ, Zhang XY. Decreased BDNF in serum of patients with chronic schizophrenia on long-term treatment with antipsychotics. Neurosci Lett 2005;382:27-32.
224. Grillo RW, Ottoni GL, Leke R, Souza DO, Portela LV, Lara DR. Reduced serum BDNF levels in schizophrenic patients on clozapine or typical antipsychotics. J Psychiatr Res 2007;41:31-35
225. Buckley PF, Pillai A, Evans D, Stirewalt E, Mahadik S. Brain derived neurotropic factor in first-episode psychosis. Schizophr Res 2007;91:1-5.
226. Hebb DO. The organization of behavior. New York:Wiley, 1949.
227. Katz LC, Shatz CJ. Synaptic activity and the construction of cortical circuits. Science 1996;274:1133-1138
228. Bi GQ, Poo MM. Synaptic modifications in cultured hippocampal neurons: dependence on spike timing, synaptic strength, and postsynaptic cell type. J Neurosci 1998;18:10464-10472
229. Harris KD. Neural signatures of cell assembly organization. Nat Rev Neurosci 2005;6:399-407.
230. Harris KD, Csicsvari J, Hirase H, Dragoi G, Buzsaki G. Organization of cell assemblies in the hippocampus. Nature 2003;424:552-556
231. Magee JC, Johnston D. A synaptically controlled, associative signal for Hebbian plasticity in hippocampal neurons. Science 1997;275:209-213
232. Konig P, Engel AK, SingerW. Integrator or coincidence detector? The role of the cortical neuron revisited. Trends Neurosci 1996;19:130-137
233. Wespatat V, Tennigkeit F, Singer W. Phase sensitivity of synaptic modifications in oscillating cells of rat visual cortex. J Neurosci 2004;24:9067-9075
234. Keshavan MS, Anderson S, Pettegrew JW. Is schizophrenia due to excessive synaptic pruning in the prefrontal cortex? The Feinberg hypothesis revisited. J Psychiatr Res 1994;28:239-265
235. Feinberg I. Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence? J Psychiatr Res 1982;17:319-334
236. Caldeira MV, Melo CV, Pereira DB, Carvalho RF, Carvalho AL, Duarte CB. BDNF regulates the expression and traffic of NMDA receptors in cultured hippocampal neurons. Mol Cell Neurosci 2007;35:208-219
237. Glazner GW, Mattson MP. Differential effects of BDNF, ADNF9, and TNFalpha on levels of NMDA receptor subunits, calcium homeostasis, and neuronal vulnerability to excitotoxicity. Exp Neurol 2000;161:442-452
238. Margottil E, Domenici L. NR2A but not NR2B N-methyl- D-aspartate receptor subunit is altered in the visual cortex of BDNF-knock-out mice. Cell Mol Neurobiol 2003;23:165-174
239. Small DL, Murray CL, Mealing GA, Poulter MO, Buchan AM, Morley P. Brain derived neurotrophic factor induction of Nmethyl- D-aspartate receptor subunit NR2A expression in cultured rat cortical neurons. Neurosci Lett 1998;252:211-214
240. Homayoun H, Moghaddam B. NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons. J Neurosci 2007;27:11496-11500
241. Pantelis C, Velakoulis D, McGorry PD, et al. Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet 2003;361:281-288
242. Job DE, Whalley HC, McIntosh AM, Owens DG, Johnstone EC, Lawrie SM. Grey matter changes can improve the prediction of schizophrenia in subjects at high risk. BMC Med 2006;4:29.
243. Job DE, Whalley HC, Johnstone EC, Lawrie SM. Grey matter changes over time in high risk subjects developing schizophrenia. Neuroimage 2005;25:1023-1030
244. DeLisi LE, Sakuma M, Tew W, Kushner M, Hoff AL, Grimson R. Schizophrenia as a chronic active brain process: a study of progressive brain structural change subsequent to the onset of schizophrenia. Psychiatry Res 1997;74: 129-140
245. Cahn W, Hulshoff Pol HE, Lems EB, et al. Brain volume changes in first-episode schizophrenia: a 1-year follow-up study. Arch Gen Psychiatry 2002;59:1002-1010
246. Ho BC, Andreasen NC, Nopoulos P, Arndt S, Magnotta V, Flaum M. Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia. Arch Gen Psychiatry 2003;60:585-594
247. Salisbury DF, Kuroki N, Kasai K, Shenton ME, McCarley RW. Progressive and interrelated functional and structural evidence of post-onset brain reduction in schizophrenia. Arch Gen Psychiatry 2007;64:521-529
248. Goff DC, Coyle JT. The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. Am J Psychiatry 2001;158:1367-1377
249. Goff DC, Leahy L, Berman I, et al. A placebo-controlled pilot study of the ampakine CX516 added to clozapine in schizophrenia. J Clin Psychopharmacol 2001;21:484-487
250. Javitt DC. Glutamate as a therapeutic target in psychiatric disorders. Mol Psychiatry 2004;9:984-97, 979.
251. Tsai G, Lane HY, Yang P, Chong MY, Lange N. Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to antipsychotics for the treatment of schizophrenia. Biol Psychiatry 2004;55:452-456
252. Moghaddam B. Targeting metabotropic glutamate receptors for treatment of the cognitive symptoms of schizophrenia. Psychopharmacology (Berl) 2004;174:39-44.
253. Krystal JH, D'Souza DC, Mathalon D, Perry E, Belger A, Hoffman R. NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development. Psychopharmacology (Berl) 2003;169:215-233
254. Patil ST, Zhang L, Martenyi F, et al. Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized phase 2 clinical trial. Nat Med 2007;13:1102-1107
255. Muly EC, Maddox M, Smith Y. Distribution of mGluR1alpha and mGluR5 immunolabeling in primate prefrontal cortex. J Comp Neurol 2003;467:521-535
256. Tennigkeit F, Fukuda T, Geiger JR. Long-lasting plasticity emerges in adult neocortical fast-spiking interneurons. Soc Neurosci Abstr 2006;35.
257. Whittington MA, Traub RD, Jefferys JG. Synchronized oscillations in interneuron networks driven by metabotropic glutamate receptor activation. Nature 1995;373:612-615
258. Gillies MJ, Traub RD, LeBeau FE, et al. A model of atropineresistant theta oscillations in rat hippocampal area CA1. J Physiol 2002;543:779-793
259. Martin SJ. Activation of metabotropic glutamate receptors induces gamma frequency oscillations in the rat dentate gyrus in vivo. Neuropharmacology 2001;40:634-637
260. Roopun AK, Cunningham MO, Racca C, Alter K, Traub RD, WhittingtonMA. Region-specific changes in gamma and beta2 rhythms in NMDA receptor dysfunction models of schizophrenia. Schizophr Bull 2008;34:962-973
261. Lewis DA, Cho RY, Carter CS, et al. Subunit-selectivemodulation of GABA type A receptor neurotransmission and cognition in schizophrenia. Am J Psychiatry 2008;165:1585-1593
262. Freund TF, Katona I. Perisomatic inhibition. Neuron 2007;56:33-42.
263. Virgo L, Humphries C, Mortimer A, Barnes T, Hirsch S, de Belleroche J. Cholecystokinin messenger RNA deficit in frontal and temporal cerebral cortex in schizophrenia. Biol Psychiatry 1995;37:694-701.
264. Katona I, Rancz EA, Acsady L, et al. Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission. J Neurosci 2001;21:9506-9518
265. Katona I, Sperlagh B, Sik A, et al. Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J Neurosci 1999;19:4544-4558
266. Beinfeld MC, Connolly K. Activation of CB1 cannabinoid receptors in rat hippocampal slices inhibits potassium-evoked cholecystokinin release, a possible mechanism contributing to the spatial memory defects produced by cannabinoids. Neurosci Lett 2001;301:69-71.
267. Hajos N, Katona I, Naiem SS, et al. Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations. Eur J Neurosci 2000;12:3239-3249
268. Broome MR, Woolley JB, Tabraham P, et al. What causes the onset of psychosis? Schizophr Res 2005;79:23-34.
269. Semple DM, McIntosh AM, Lawrie SM. Cannabis as a risk factor for psychosis: systematic review. J Psychopharmacol 2005;19:187-194
270. Moore TH, Zammit S, Lingford-Hughes A, et al. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 2007;370:319-328
271. Skosnik PD, Krishnan GP, Aydt EE, Kuhlenshmidt HA, O'Donnell BF. Psychophysiological evidence of altered neural synchronization in cannabis use: relationship to schizotypy. Am J Psychiatry 2006;163:1798-1805
272. Hajos M, Hoffmann WE, Kocsis B. Activation of cannabinoid- 1 receptors disrupts sensory gating and neuronal oscillation: relevance to schizophrenia. Biol Psychiatry 2008;63: 1075-1083
273. Freedman R, Wetmore C, Stromberg I, Leonard S, Olson L. Alpha-bungarotoxin binding to hippocampal interneurons: immunocytochemical characterization and effects on growth factor expression. J Neurosci 1993;13:1965-1975
274. Frazier CJ, Rollins YD, Breese CR, Leonard S, Freedman R, Dunwiddie TV. Acetylcholine activates an alphabungarotoxin- sensitive nicotinic current in rat hippocampal interneurons, but not pyramidal cells. J Neurosci 1998;18:1187-1195
275. Martin LF, Kem WR, Freedman R. Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia. Psychopharmacology (Berl) 2004;174: 54-64.
276. Olincy A, Harris JG, Johnson LL, et al. Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia. Arch Gen Psychiatry 2006;63:630-638
277. Crawford HJ, McClain-Furmanski D, Castagnoli N, Jr., Castagnoli K. Enhancement of auditory sensory gating and stimulus-bound gamma band (40 Hz) oscillations in heavy tobacco smokers. Neurosci Lett 2002;317: 151-155
278. Brown S, Birtwistle J, Roe L, Thompson C. The unhealthy lifestyle of people with schizophrenia. Psychol Med 1999;29:697-701.
279. Dalack GW, Meador-Woodruff JH. Smoking, smoking withdrawal and schizophrenia: case reports and a review of the literature. Schizophr Res 1996;22:133-141